Literature DB >> 7028073

Phagocytic and bactericidal activity of human neutrophils against two isolates of Group B streptococci Type Ic of differing pathogenicity.

P H Cleat, C R Coid.   

Abstract

The phagocytic and bactericidal activities of normal adult human neutrophils against 2 strains of Group B streptococci Type Ic of differing pathogenicity were examined. Both isolates were phagocytosed by the neutrophils in the presence of normal and homologous immune serum. However, the highly pathogenicity streptococci were killed less readily in the presence of immune serum than were the streptococci of low pathogenicity in the presence of immune or normal serum. This difference in killing ability was not due to a defect in phagocytosis by the neutrophils, but to a defect in bactericidal activity. The highly pathogenic streptococci were not killed in the presence of normal serum, but were readily phagocytosed by the neutrophils, in which they accumulated and eventually caused their destruction. The streptococci of low pathogenicity, however, were killed equally as well in the absence of specific antibody as in its presence. It is suggested that an in vitro assessment of neutrophil function against streptococci of differing pathogenicity for mice may provide a useful method by which the pathogenicity of streptococci for man can be compared.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028073      PMCID: PMC2041681     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  24 in total

1.  Effects of streptococcal cell wall fragments on phagocytosis and tissue culture cells.

Authors:  J M Jones; J H Schwab
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

2.  Acquired defect in the bactericidal function of neutrophil granulocytes during bacterial infections.

Authors:  C Koch
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-06

3.  Neutrophil granulocyte function in bacterial infections.

Authors:  C O Solberg; K B Hellum
Journal:  Lancet       Date:  1972-10-07       Impact factor: 79.321

4.  Influence of phenylbutazone on the phagocytic and bactericidal activities of neutrophil granulocytes.

Authors:  C O Solberg
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-04

5.  The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement.

Authors:  C J Howard; A A Glynn
Journal:  Immunology       Date:  1971-05       Impact factor: 7.397

6.  Influence of the cell surface lipopolysaccharide structure of Salmonella typhimurium on resistance to intracellular bactericidal systems.

Authors:  C Tagesson; O Stendahl
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973-08

7.  Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers.

Authors:  B J Wilkinson; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

8.  Antibody levels in mothers colonised with group B streptococci during pregnancy and in their newborn infants, as measured by an enzyme linked immunosorbent assay.

Authors:  P H Cleat; J Ross; J R Needham
Journal:  Med Microbiol Immunol       Date:  1980-02       Impact factor: 3.402

9.  The survival of staphylococci within human leukocytes.

Authors:  D E ROGERS; R TOMPSETT
Journal:  J Exp Med       Date:  1952-02       Impact factor: 14.307

10.  Interactions between rabbit polymorphonuclear leucocytes and staphylococci.

Authors:  Z A COHN; S I MORSE
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

View more
  7 in total

1.  The mode of action of antibody in neutrophil bactericidal activity against highly pathogenic group-B streptococci.

Authors:  P H Cleat; C R Coid
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

2.  An alternative role for specific antibody in neutrophil bactericidal activity against highly pathogenic group B streptococci.

Authors:  P H Cleat; C R Coid
Journal:  Br J Exp Pathol       Date:  1982-08

3.  Cloning and expression in Escherichia coli of the Ibc protein genes of group B streptococci: binding of human immunoglobulin A to the beta antigen.

Authors:  P H Cleat; K N Timmis
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

4.  Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.

Authors:  N R Payne; Y K Kim; P Ferrieri
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

5.  Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).

Authors:  C von Hunolstein; S D'Ascenzi; B Wagner; J Jelínková; G Alfarone; S Recchia; M Wagner; G Orefici
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

6.  Sialic acid levels and lag time of growth in chemically defined medium containing 200 mM phosphate among strains of various serotypes of Streptococcus agalactiae.

Authors:  Y Nagano; N Nagano; S Takahashi; A Suzuki; Y Okuwaki
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

7.  Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.